Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Nov 22, 2024 7:21am
43 Views
Post# 36325435

Interesting comment Bart Hendriks on this post.

Interesting comment Bart Hendriks on this post.Interesting comment Bart Hendriks on this post & remember Ventripoint 
Team Connection at Ventripoint: A Meeting to Remember!

Thrilled with the energy from our visit to Ventripoint Diagnostics Ltd. Headquarters in Toronto!

Our visit was not only productive but also incredibly inspiring. From brainstorming sessions to strategic meetings, we dove deep into collaborative talks that are sure to shape the future of pediatric cardiology.

A huge shout-out to everyone at Ventripoint for the warm welcome and the engaging exchanges. We're excited about the partnerships we're fostering and the shared vision we're bringing to life.

Here's to more fruitful meetings and to the success that comes from working together!
Another Milestone for SavvyWire in Germany!

After last week’s first SavvyWire case in Germany, we’re thrilled to announce that this week saw the first SavvyWire case in Nordrhein-Westfalen!

A huge congratulations to the amazing team at
Uniklinik Kln hashtagHerzzentrumKln led by Dr. Matti Adam for successfully showcasing the benefits of the all-in-one system, combining hemodynamic monitoring, rapid pacing, and guidewire functionality into a single, streamlined tool.

With every step, SavvyWire is transforming TAVI procedures—simplifying workflows and improving outcomes for patients across Germany.

hashtagSavvyWire hashtagTAVI hashtagCardiology hashtagHemodynamics hashtagRapidPacing hashtagInnovationInHealth hashtagAngiopro hashtagFirstCase
 
 
 
 

 

 
Ajouter un commentaire…
 
 

<< Previous
Bullboard Posts
Next >>